Precisely Inhibiting Excessive Intestinal Epithelial Cell Apoptosis to Efficiently Treat Inflammatory Bowel Disease with Oral Pifithrin‐α Embedded Nanomedicine (OPEN)
Advanced Materials · 2023
DOI: 10.1002/adma.202309370 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2023. Verfasst von Mingyuan Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric Surgery, Xiangya Hospital, Central South University, Changsha, 410078, China. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Hunan Science Fund for Distinguished Young Scholar of China, Hunan Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
The increased incidence of inflammatory bowel disease (IBD) has seriously affected the life quality of patients. IBD develops due to excessive intestinal epithelial cell (IEC) apoptosis, disrupting the gut barrier, colonizing harmful bacteria, and initiating persistent inflammation. The current therapeutic approaches that reduce inflammation are limited. Although IBD can be treated significantly by directly preventing IEC apoptosis, achieving this therapeutic approach remains challenging. Accordingly, the authors are the first to develop an oral pifithrin‐α (PFTα, a highly specific p53 inhibitor) embedded nanomedicine (OPEN) to effectively treat IBD by inhibiting excessive IEC apoptosis. As a major hub for various stressors, p53 is a central determinant of cell fate, and its inhibition can effectively reduce excessive IEC apoptosis. The tailored OPEN can precisely inhibit the off‐target and inactivation resulting from PFTα entry into the bloodstream. Subsequently, it persistently targets IBD lesions with high specificity to inhibit the pathological events caused by excessive IEC apoptosis. Eventually, OPEN exerts a significant curative effect compared with the clinical first‐line drugs 5‐aminosalicylic acid (5‐ASA) and dexamethasone (DEX). Consequently, the OPEN therapeutic strategy provides new insights into comprehensive IBD therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatric Surgery, Xiangya Hospital, Central South University, Changsha, 410078, China.
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410008, China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410078, China.
- Department of General Surgery, Xiangya Hospital, Central South University, Changsha, 410078, China.
- Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, 410078, China.
- Hunan Provincial Key Laboratory of Cardiovascular Research, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410008, China.
ORCID-Profile: Mingyuan Wang, Kelong Ai
Förderung
- National Natural Science Foundation of China
- Hunan Science Fund for Distinguished Young Scholar of China
- Hunan Provincial Natural Science Foundation of China
- Innovation-Driven Project of Central South University
- Central South University Research Program of Advanced Interdisciplinary Studies
- Key Research Project of Ningxia Hui Autonomous Region of China
- The Key Program of Ningxia Hui Autonomous Region Natural Science Foundation of China
Zitieren
APA
Wang, M., Huang, Q., Liu, M., Zhao, T., Song, X., Chen, Q., Yang, Y., Nan, Y., Liu, Z., Zhang, Y., Wu, W., & Ai, K. (2023). Precisely Inhibiting Excessive Intestinal Epithelial Cell Apoptosis to Efficiently Treat Inflammatory Bowel Disease with Oral Pifithrin‐α Embedded Nanomedicine (OPEN). Advanced Materials. https://doi.org/10.1002/adma.202309370
Vancouver
Wang M, Huang Q, Liu M, Zhao T, Song X, Chen Q, et al. Precisely Inhibiting Excessive Intestinal Epithelial Cell Apoptosis to Efficiently Treat Inflammatory Bowel Disease with Oral Pifithrin‐α Embedded Nanomedicine (OPEN). Advanced Materials. 2023. doi:10.1002/adma.202309370
BibTeX
@article{Wang2023,
author = {Wang, Mingyuan and Huang, Qiong and Liu, Min and Zhao, Tianjiao and Song, Xiangping and Chen, Qiaohui and Yang, Yongqi and Nan, Yayun and Liu, Zerun and Zhang, Yuntao and Wu, Wei and Ai, Kelong},
title = {Precisely Inhibiting Excessive Intestinal Epithelial Cell Apoptosis to Efficiently Treat Inflammatory Bowel Disease with Oral Pifithrin‐α Embedded Nanomedicine (OPEN)},
journal = {Advanced Materials},
year = {2023},
doi = {10.1002/adma.202309370}
}
EUVIMED